Pergoveris 150/75
Pergoveris 150/75 is a medicine authorised by Swissmedic under authorisation number 69476. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 March 2024 and the authorisation is limited until 27 March 2029. The export lists no ATC code for this medicine.
| Authorisation number | 69476 |
|---|---|
| Name | Pergoveris 150/75 |
| Full name | Pergoveris 150/75, Pulver zur Herstellung einer Injektionslösung |
| Authorisation holder | Merck (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | not stated |
| First authorisation | 28 March 2024 |
| Authorisation validity | 27 March 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pergoveris 150/75, Pulver zur Herstellung einer Injektionslösung | A | 28 March 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Pergoveris 150/75 authorised in Switzerland?
Yes. Pergoveris 150/75 is authorised by Swissmedic under authorisation number 69476, data as of 01 September 2026. The authorisation is limited until 27 March 2029.
Which dispensing category does Pergoveris 150/75 have?
Pergoveris 150/75 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pergoveris 150/75?
The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.